ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.
View Top Employees from ENYO Pharma| Website | http://www.enyopharma.com |
| Revenue | $7 million |
| Funding | $66.7 million |
| Employees | 31 (26 on RocketReach) |
| Founded | 2014 |
| Address | 60 Ave Rockefeller, Lyon, Auvergne-Rhone-Alpes 69008, FR |
| Phone | +33 4 37 70 02 19 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Drug Discovery, Manufacturing, Pharmaceuticals |
| Web Rank | 2 Million |
| Keywords | Transformation Prince, Mfp M775, Nettoyer Un Profil Distant Ad, Enyo Pharma, Traduction |
| Competitors | Abivax, Aptahem, KBP Biosciences, ManRos Therapeutics, Patrys Limited |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular ENYO Pharma employee's phone or email?
ENYO Pharma Questions
The ENYO Pharma annual revenue was $7 million in 2024.
Nicolas Guyon-Gellin is the Vice President Corporate Development and Strategy of ENYO Pharma.
26 people are employed at ENYO Pharma.
ENYO Pharma is based in Lyon, Auvergne-Rhone-Alpes.
The NAICS codes for ENYO Pharma are [325, 32541, 32, 3254].
The SIC codes for ENYO Pharma are [283, 28].
Top ENYO Pharma Employees
-
ViewNicolas Guyon-Gellin
Vice President Corporate Development and Strategy at ENYO Pharma
Lyon, Auvergne-Rhône-Alpes, France34 -
41
-
4
-
ViewNicolas Guyon-Gellin
Vice President Corporate Development and Strategy at ENYO Pharma
Lyon, Auvergne-Rhône-Alpes, France24 -
ViewNicolas Guyon-Gellin
Vice President Corporate Development and Strategy at ENYO Pharma
Lyon, Auvergne-Rhône-Alpes, France24
Related Companies
